Hypertrophy of intramyocardial arteriolar smooth muscle cells in experimental renal failure

Journal of the American Society of Nephrology

Volumn 10, Issue 1, 1999, Pages 77-83

  Törnig, Johannes ^a   Gross, Marie Luise ^a   Simonaviciene, Aurelia ^a   Mall, Gerhard ^b   Ritz, Eberhard ^a   Amann, Kerstin ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KLINIKUM DARMSTADT   (Germany)

^c Department of Pathology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HEART WEIGHT; HYPERPLASIA; HYPERTROPHY; KIDNEY FAILURE; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE;

EID: 0344389052     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. U.S. Renal Data System: Causes of death. Annual Data Report 14: 79-90, 1995
2. European Dialysis and Transplantation Association: Report on management in renal failure in Europe, XXII, 1993. Nephrol Dial Transplant 10[Suppl 5]: 12, 1995
3. Raine AEG, Seymour AML, Roberts AFC, Radda GK, Ledingham JGG: Impairment of cardiac function and energetics in experimental renal failure. J Clin Invest 92: 2934-2940, 1993
4. Ritz E, Rambausek M, Mall G, Rufmann K, Mandelbaum A: Cardiac changes in uremia and their possible relationship to cardiovascular instability on dialysis. Nephrol Dial Transplant 1: 93-97, 1990
5. London GM, Fabiani F, Marchais SJ, de Vernejoul MC, Guerin AP, Safar ME, Metivier F, Llach F: Uremic cardiomyopathy: An inadequate left ventricular hypertrophy. Kidney Int 31: 973-980, 1987
6. London GM, Zins B, Pannier B, Naret C, Berthelot JM, Jacquot C, Safar ME, Druecke TB: Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. Kidney Int 36: 878-882, 1989
7. London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F, Chedid K, London AM: Aortic and large artery compliance in end-stage renal failure. Kidney Int 37: 137-142, 1990
8. London GM, Pannier B, Marchais SJ, Benetos B, Safar ME: Increased systolic pressure in chronic uremia. Role of arterial wave reflection. Hypertension 20: 10-19, 1992
9. London GM: Increased arterial stiffness in end-stage renal failure: Why is it of interest to the clinical nephrologist? Nephrol Dial Transplant 9: 1709-1712, 1994
10. Ritz E, Koch M: Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 21: 113-118, 1993
11. Gwathmey JK, Copelas L, Mackinnon, Schoen FJ, Feldman MD, Grossmann W, Morgan JP: Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61: 70-76, 1987
12. Amann K, Wiest G, Zimmer G, Gretz N, Ritz E, Mall G: Reduced capillary density in the myocardium of uremic rats: A stereological study. Kidney Int 42: 1079-1085, 1992
13. Amann K, Neusüss R, Ritz E, Irzyniec T, Wiest G, Mall G: Changes of vascular architecture independent of blood pressure in experimental uremia. Am J Hypertens 8: 409-417, 1995
14. Mall G, Rambausek M, Neumeister A, Kollmar S, Vetterlein F, Ritz E: Myocardial interstitial fibrosis in experimental uremia: Implications for cardiac compliance. Kidney Int 33: 804-811, 1988
15. Mall G, Huther W, Schneider J, Lundin P, Ritz E: Diffuse intermyocardiocytic fibrosis in uremic patients. Nephrol Dial Transplant 5: 39-44, 1990
16. Amann K, Ritz E: Cardiac disease in chronic uremia. Adv Ren Replace Ther 4: 212-224, 1997
17. Rostand SG, Brunzell JD, Cannon RO 3d, Victor RG: Cardiovascular complications in renal failure [Editorial]. J Am Soc Nephrol 2: 1053-1062, 1991
18. Rostand SG, Kirk KA, Rutsky EA: Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kidney Int 25: 653-659, 1984
19. Rutzky E, Rostand SG: The management of coronary artery disease in patients with end-stage disease. In: Cardiac Dysfunction in Chronic Uremia, edited by Parfrey PS, Harnett JD, Dordrecht, Kluwer, 1992, p 231
20. Barenbrock M, Spieker C, Laske V, Heidenreich S, Bachmann HHJ, Hoeks APG, Rahn KH: Studies of the vessel wall properties in hemodialysis patients. Kidney Int 45: 1397-1400, 1994
21. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE: Structural alterations of the intramyocardial arterioles in patients with arterial hypertension. Circulation 88: 993-1003, 1993
22. Amann K, Gharehbaghi H, Stephan S, Mall G: Hypertrophy and hyperplasia of smooth muscle cells of small intramyocardial arteries in spontaneously hypertensive rats. Hypertension 25: 124-131, 1995
23. Amann K, Schwarz U, Törnig J, Stein G, Ritz E: Some cardiac abnormalities in renal failure. In: Actualités Néphrologiques Jean Hamburger: Hôpital Necker 1997, edited by Grünfeld JP, Bach JF, Kreis H, Paris, Médecine-Sciences Flammarion, 1997, pp 1-15
24. Amann K, Kronenberg G, Gehlen F, Orth SR, Münter K, Ehmke H, Mall G, Ritz E: Cardiac remodeling in experimental renal failure: An immunohistochemical study. Nephrol Dial Transplant 13: 1958-1966, 1998
25. Törnig J, Amann K, Ritz E, Nichols C, Zeier M, Mall G: Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: The effect of ramipril, nifedipine and moxonidine. J Am Soc Nephrol 7: 669-677, 1996
26. Gross ML, Amann K, Münter K, Schwarz U, Orth SR, Ritz E: Role of the endothelin system in uremic cardiomyopathy [Abstract]. J Am Soc Nephrol 8: 616A-617A, 1997
27. Mattfeldt T, Mall G, Gharehbaghi H, Möller P: Estimation of surface area and length with the orientator. J Microsc 159: 301-317, 1990
28. Wiest G, Gharehbaghi H, Amann K, Simon T, Mattfeldt T, Mall G: Physiologic growth of arteries in the rat heart parallels the growth of capillaries, but not of myocytes. J Mol Cell Cardiol 24: 1423-1431, 1992
29. Weibel ER: Stereological Methods, Volume I. Practical Methods for Biological Morphometry, Volume I, London, Academic Press, 1979
30. Weibel ER: Stereological Methods, Volume II. Theoretical Foundation, London, Academic Press, 1980
31. Gundersen HJG: The nucleator. J Microsc 151: 3-21, 1988
32. Cruz-Orive LM: Particle number can be estimated using a dissector of unknown thickness: The selector. J Microsc 145: 121-142, 1987
33. Gundersen HJG: Stereology of arbitrary particles: A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J Microsc 143: 3-45, 1986
34. Mulvany MJ, Baandrup U, Gundersen HJG: Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three dimensional dissector. Circ Res 57: 794-800, 1985
35. Bidani AK, Griffin KA, Picken M, Lansky DM: Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model. Am J Physiol 265: F391-F398, 1993
36. Amann K, Wolf B, Nichols C, Törnig J, Schwarz U, Zeier M, Mall G, Ritz E: Aortic changes in experimental renal failure: Hyperplasia or hypertrophy of smooth muscle cells. Hypertension 29: 770-775, 1997
37. Gross ML, Amann K, Nabokov A, Schwarz U, Orth SR, Ritz E: Endothelin receptor antagonists prevent cardiovascular abnormalities in renal failure independent of blood pressure reduction [Abstract]. Nieren Hochdruckkr 9: 404, 1997
38. Demuth K, Blacher J, Guerin A: Endothelin and cardiovascular remodeling in end-stage renal disease. Nephrol Dial Transplant 13: 375-383, 1998
39. Chua BH, Krebs CJ, Chua CC, Diglio CA: Endothelin stimulates protein synthesis in smooth muscle cells. Am J Physiol 262: E412-E416, 1992
40. Weber H, Webb ML, Serafino R, Taylor DS, Moreland S, Norman J, Moloy CJ: Endothelin-I and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: Evidence for common signaling mechanism. Mol Endocrinol 8: 148-158, 1994
41. Barton M, Shaw S, D'Uscio LV, Moreau P, Lüscher TF: Angiotensin II increases vascular and renal endothelin-1 and functional endothelin convening enzyme activity in vivo: Role of ET-A receptors for endothelin regulation. Biochem Biophys Res Commun 238: 861-865, 1997
42. Moraves CS, Reynolds EE, Stewart RW, Bond M: Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun 159: 14-18, 1989
43. Galaktionov K, Xiaocun C, Beach D: Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382: 511-517, 1996
44. Naftilan AJ, Pratt RE, Dzau VJ: Induction of platelet-derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 83: 1419-1424, 1989
45. Kuczera M, Hilgers KF, Lisson C, Ganten D, Hilgenfeld U, Ritz E, Mann JFE: Local angiotensin formation in hindlimbs of uremic hypertensive and renovascular hypertensive rats. J Hypertens 9: 41-48, 1991
46. Amann K, Törnig J, Flechtenmacher C, Nabokov A, Mall G, Ritz E: Blood pressure independent wall thickening of intramyocardial arterioles in experimental uremia: Evidence for a permissive action of PTH. Nephrol Dial Transplant 10: 2043-2048, 1995
47. Pirola CJ, Wang H, Kamyar A, Wu S, Enomoto H, Sharifi B, Forrester JS, Clemens TL, Fagin JA: Angiotensin II regulates parathyroid hormone-related protein expression in cultured rat aortic smooth muscle cells through transcriptional and posttranslational mechanisms. J Biol Chem 268: 1987-1994, 1993
48. Okano K, Pirola CJ, Wang HM, Forrester JS, Fagin JA, Clemens TL: Involvement of cell cycle and mitogen-activated pathways in induction of parathyroid hormone-related protein gene expression in rat aortic smooth muscle cells. Endocrinology 136: 1782-1789, 1995
49. Urena P, Kubrusly M, Mannstadt M, Hruhy M, Trinh MM, Silve C, Lacour B, Abou-Samra AB, Segre GV, Drucke T: The renal PTH/PTHrp receptor is down regulated in rats with chronic renal failure. Kidney INt 45: 605-611, 1994